Literature DB >> 18701919

The prevalence of erectile dysfunction in heart failure patients by race and ethnicity.

K Herbert1, B Lopez, J Castellano, A Palacio, L Tamari, L M Arcemen.   

Abstract

Erectile dysfunction (ED) is a common problem in male patients with heart failure (HF). However, no study was found that estimates the prevalence of ED by US ethnic groups with HF. We conducted an observational, cross-sectional study of patients enrolled in a HF disease management program in two sites Louisiana (N=329; 178 white, 99 black) and Florida (N=52; Hispanic). All male patients with an ejection fraction <or=40% were included. The Sexual Health Inventory for Men was used to estimate the prevalence of ED. Overall prevalence of ED was 89% and ED severity did not vary by race/ethnic group. Race/ethnic group differences were found for age, New York Heart Association functional classification, and blood pressure. Hispanic patients had the lowest unadjusted and adjusted prevalence rate of ED (81, 85%) compared to Black (90, 95%) and White (91, 92%) patients. There is a high prevalence of ED in Hispanic, Black and White ethnic groups with HF.

Entities:  

Mesh:

Year:  2008        PMID: 18701919     DOI: 10.1038/ijir.2008.35

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  6 in total

Review 1.  Sexual dysfunction in heart failure patients.

Authors:  Tiny Jaarsma; Bengt Fridlund; Jan Mårtensson
Journal:  Curr Heart Fail Rep       Date:  2014-09

2.  A novel experimental model of erectile dysfunction in rats with heart failure using volume overload.

Authors:  Fábio Henrique Silva; Frederico José Reis Veiga; Aline Gonçalves Mora; Rodrigo Sader Heck; Caroline Candida De Oliveira; Alessandra Gambero; Carla Fernanda Franco-Penteado; Edson Antunes; Jason D Gardner; Fernanda Bruschi Marinho Priviero; Mário Angelo Claudino
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

3.  Sexual function of patients with heart failure: facts and numbers.

Authors:  Tiny Jaarsma
Journal:  ESC Heart Fail       Date:  2016-09-14

Review 4.  Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

Authors:  H Al-Ameri; R A Kloner
Journal:  Int J Impot Res       Date:  2009-04-23       Impact factor: 2.896

5.  Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study.

Authors:  Emily Banks; Grace Joshy; Walter P Abhayaratna; Leonard Kritharides; Peter S Macdonald; Rosemary J Korda; John P Chalmers
Journal:  PLoS Med       Date:  2013-01-29       Impact factor: 11.069

6.  The CopenHeartSF trial--comprehensive sexual rehabilitation programme for male patients with implantable cardioverter defibrillator or ischaemic heart disease and impaired sexual function: protocol of a randomised clinical trial.

Authors:  Pernille Palm Johansen; Ann-Dorthe Zwisler; Jesper Hastrup-Svendsen; Marianne Frederiksen; Jane Lindschou; Per Winkel; Christian Gluud; Annamaria Giraldi; Elaine Steinke; Tiny Jaarsma; Selina Kikkenborg Berg
Journal:  BMJ Open       Date:  2013-11-25       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.